BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15650785)

  • 1. [Immunoreactivity studies on synthetic peptides deriving from immunodominant region of hepatitis C virus NS5a gene].
    Shi LL; Dou XG; Feng GH; Fields H; Khudyakov Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):344-7. PubMed ID: 15650785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic heterogeneity of the hepatitis C virus NS5A protein.
    Dou XG; Talekar G; Chang J; Dai X; Li L; Bonafonte MT; Holloway B; Fields HA; Khudyakov YE
    J Clin Microbiol; 2002 Jan; 40(1):61-7. PubMed ID: 11773093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
    Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
    Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and application of serotypical synthetic peptides derived from hepatitis C virus NS5A region.
    Dou XG; Zhang L; Li ZW; Feng GH; Chang J; Fildes H; Khudyakov Y
    Chin Med J (Engl); 2007 Jul; 120(13):1159-65. PubMed ID: 17637245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection.
    Zhang ZX; Chen M; Sönnerborg A; Sällberg M
    Clin Diagn Lab Immunol; 1994 May; 1(3):290-4. PubMed ID: 7496964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
    Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
    J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides.
    Chang JC; Seidel C; Ofenloch B; Jue DL; Fields HA; Khudyakov YE
    Virology; 1999 Apr; 257(1):177-90. PubMed ID: 10208931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
    Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.
    Simmonds P; Rose KA; Graham S; Chan SW; McOmish F; Dow BC; Follett EA; Yap PL; Marsden H
    J Clin Microbiol; 1993 Jun; 31(6):1493-503. PubMed ID: 7686182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression of NS5a strong antigenic regions of hepatitis C virus in E.coli and detection of their antigenicity.
    Dou XG; Feng GH; Shi LL; Fields H
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):383-7. PubMed ID: 14607711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity assessment of hepatitis C virus NS3 protease and NS5A proteins expressed in TOPO cloning system.
    Alaee M; Rajabi P; Sharifi Z; Farajollahi MM
    J Microbiol Immunol Infect; 2014 Aug; 47(4):282-91. PubMed ID: 23040046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection.
    Jolivet-Reynaud C; Dalbon P; Viola F; Yvon S; Paranhos-Baccala G; Piga N; Bridon L; Trabaud MA; Battail N; Sibai G; Jolivet M
    J Med Virol; 1998 Dec; 56(4):300-9. PubMed ID: 9829633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides.
    Park HJ; Byun SM; Ha YJ; Ahn JS; Moon HM
    J Immunoassay; 1995 May; 16(2):167-81. PubMed ID: 7543117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides.
    Khudyakov Yu E; Khudyakova NS; Jue DL; Lambert SB; Fang S; Fields HA
    Virology; 1995 Jan; 206(1):666-72. PubMed ID: 7530398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system.
    Buratti E; Di Michele M; Song P; Monti-Bragadin C; Scodeller EA; Baralle FE; Tisminetzky SG
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):117-21. PubMed ID: 9067642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of the heterogenicity of amino acid sequence on the immunoreactivity of an antigenic epitopic complex localized within amino acids 1192-1456 of protein NS3 protein of hepatitis C virus].
    Ulanova TI; Puzyrev VF; Burkov AN; Obriadina AP
    Vopr Virusol; 2006; 51(1):28-30. PubMed ID: 16515039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders.
    Longombardo G; Ferri C; Marchi S; Costa F; Lombardini F; Vacri L; Bombardieri S; Migliorini P
    Clin Immunol Immunopathol; 1998 May; 87(2):124-9. PubMed ID: 9614926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
    Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
    J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
    Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
    J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
    Sällberg M; Rudén U; Wahren B; Magnius LO
    Clin Exp Immunol; 1993 Mar; 91(3):489-94. PubMed ID: 7680297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.